Table 1

Study population characteristics and outcomes

ParticipantsAdvanced neoplasiaColorectal cancer
n (%)nOR95% CIP valuenOR95% CIP value
All265 881 (100)3254557
Sex
 Female138 860 (52.2)1325Ref<0.001248Ref<0.001
 Male127 021 (47.8)19291.61.5 to 1.73091.41.2 to 1.6
Age, years (mean 69.0±1.9)
 6410 778 (4.1)138Ref0.0117Ref0.11
 651118 (0.4)130.90.5 to 1.621.10.3 to 4.9
 666378 (2.4)700.90.6 to 1.1111.10.5 to 2.3
 6754 701 (20.6)6560.90.8 to 1.11071.20.7 to 2.1
 6812 793 (4.8)1561.00.8 to 1.2180.90.5 to 1.7
 6974 344 (28)8240.90.7 to 1.01481.30.8 to 2.1
 7020 189 (7.6)2481.00.8 to 1.2391.20.7 to 2.2
 7185 298 (32.1)11451.00.9 to 1.32141.61.0 to 2.6
 72282 (0.1)41.10.4 to 3.012.30.3 to 17
First F-Hb concentration, µg Hb/g faeces
 0206 983 (77.8)1356Ref<0.001273Ref<0.001
 0.1–2.527 861 (10.5)4442.52.2 to 2.7711.91.5 to 2.5
 2.6–9.919 661 (7.4)6435.14.7 to 5.6973.83.0 to 4.7
 10–19.96930 (2.6)3959.28.2 to 10.3586.44.8 to 8.5
 20–29.92258 (0.8)18313.411.4 to 15.73210.97.5 to 15.7
 30–39.91361 (0.5)12915.913.1 to 19.2137.34.2 to 12.8
 40–46.9827 (0.3)10421.817.6 to 27.01312.16.9 to 21.2
Second F-Hb concentration, µg Hb/g faeces
 0242 220 (91.1)1745Ref<0.001346Ref<0.001
 0.1–2.55322 (2.0)1744.74.0 to 5.5385.03.6 to 7.0
 2.6–9.98253 (3.1)4558.07.2 to 8.9574.93.7 to 6.4
 10–19.94887 (1.8)36211.09.8 to 12.4558.06.0 to 10.6
 20–29.92362 (0.9)23014.912.9 to 17.2257.55.0 to 11.2
 30–39.91742 (0.7)17315.212.9 to 17.9228.95.8 to 13.8
 40–46.91095 (0.4)11516.213.3 to 19.7149.15.3 to 15.5
  • ORs were based on raw numbers. Adjusted ORs are presented in table 2. Associations were examined using Pearson’s χ2 test.

  • F-Hb, faecal haemoglobin.